Niocorp Developments Ltd (NB) · Oct 16, 2026 · Material agreement
15-year offtake — 50% ferroniobium take-or-pay; exclusive marketing for 100% of other products
NioCorp’s new offtake agreement places Elk Creek’s planned output under commercial coverage, but project financing remains the key hurdle.
NioCorp is still a pre-production developer trying to finance and build its Elk Creek critical-minerals project in Nebraska; early construction has begun, but the roughly $1.85 billion project remains dependent on project financing and EXIM’s due-diligence process. This removes a meaningful commercialization gap. ECRC has replaced its older Traxys arrangements with a binding 15-year agreement covering ferroniobium, scandium, titanium and multiple rare-earth products. 〔0〕 The contract makes Traxys responsible for buying 50% of planned ferroniobium production on a take-or-pay basis and gives it exclusive marketing rights for 100% of the other listed products. 〔1〕 〔2〕 The key improvement is binding scope, not a wholly unexpected direction. NioCorp had already disclosed a non-binding April 2026 term sheet that contemplated Traxys marketing the remaining planned output, so the market knew the broad destination. The new information is that the arrangement is now definitive, extends to 15 years rather than the earlier 10-year framework, and adds a take-or-pay commitment for half of ferroniobium. It helps bankability but does not solve the funding problem. The agreement is expressly terminable if EXIM has not finally approved senior debt financing or financial close has not occurred by December 31, 2027. 〔3〕 That makes the agreement supportive evidence for lenders—not evidence that construction financing is secured. There is also some economics left open. Product prices are linked to published market prices, while Traxys deducts commissions and logistics, marketing and financing costs; the filing therefore establishes a sales channel but does not disclose guaranteed revenue, minimum pricing for most products, or a financing commitment. Bottom line: This is a real step forward from a non-binding commercialization plan to a broader, binding sales framework. It strengthens Elk Creek’s financeability, but the project story still hinges on EXIM approval and financial close rather than offtake alone.
EXIM approval and financial close by December 31, 2027
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!